Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 4Neoplastic Cells, Circulating 1

Interventions

Blood Specimen Collection 6Trastuzumab 2Liquid Biopsy 2Cyclophosphamide 2Carboplatin 2ribociclib 1pertuzumab 1eribulin 1Zoledronic Acid 1Watchful Waiting 1Thiotepa 1Surgical Procedures, Operative 1Stem Cell Transplantation 1Standard of Care 1Reverse Transcriptase Polymerase Chain Reaction 1Positron Emission Tomography Computed Tomography 1Paclitaxel 1Microfluidics 1Letrozole 1Lapatinib 1Fulvestrant 1Flow Cytometry 1Epirubicin 1Diphosphonates 1Digoxin 1Denosumab 1Biopsy 1Atorvastatin 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplastic Cells, Circulating × Digoxin × Breast × Clear all
NCT03928210 2023-12-13

Digoxin Induced Dissolution of CTC Clusters

University Hospital, Basel, Switzerland

Phase EARLY_PHASE1 Completed
58 enrolled
Breast

Breast Neoplasms, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡